Literature DB >> 6310508

The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1.

G Stanway, A J Cann, R Hauptmann, P Hughes, L D Clarke, R C Mountford, P D Minor, G C Schild, J W Almond.   

Abstract

The complete nucleotide sequence of the genome of the Sabin vaccine strain of poliovirus type 3 (P3/Leon 12 a1 b) has been determined from cDNA cloned in E. coli. The genome comprises a 5' non-coding region of 742 nucleotides, a large open reading frame of 6618 nucleotides (89% of the sequence) and a 3' non-coding region of 72 nucleotides. There is 77.4% base-sequence homology and 89.6% predicted amino-acid homology between types 1 and 3. Conservation of all glutamine-glycine and tyrosine-glycine cleavage sites suggests a mechanism of polyprotein processing similar to that established for poliovirus type 1.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6310508      PMCID： PMC326302          DOI： 10.1093/nar/11.16.5629

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


  29 in total

1.  3'-Terminal nucleotide sequences in the genome RNA of picornaviruses.

Authors:  A G Porter; P Fellner; D N Black; D J Rowlands; T J Harris; F Brown
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

2.  5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical.

Authors:  R F Pettersson; J B Flanegan; J K Rose; D Baltimore
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

3.  Size of gene sequences shared by polioviruses types 1, 2, and 3.

Authors:  N A Young
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

4.  Polypeptide cleavages in the formation of poliovirus proteins.

Authors:  M F Jacobson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

5.  A simple method for DNA restriction site mapping.

Authors:  H O Smith; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

6.  5'-terminal structure of poliovirus polyribosomal RNA is pUp.

Authors:  M J Hewlett; J K Rose; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

7.  Evolution of poliovirus since introduction of attenuated vaccine.

Authors:  Y E Cossart
Journal:  Br Med J       Date:  1977-06-25

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  A protein covalently linked to poliovirus genome RNA.

Authors:  Y F Lee; A Nomoto; B M Detjen; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

10.  Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.

Authors:  A Nomoto; T Omata; H Toyoda; S Kuge; H Horie; Y Kataoka; Y Genba; Y Nakano; N Imura
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205
View more
  62 in total

1.  A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA.

Authors:  N Percy; W S Barclay; M Sullivan; J W Almond
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.

Authors:  J M Tatem; C Weeks-Levy; A Georgiu; S J DiMichele; E J Gorgacz; V R Racaniello; F R Cano; S J Mento
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells.

Authors:  Stephanie A Campbell; Jennifer Lin; Elena Y Dobrikova; Matthias Gromeier
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.

Authors:  K M Chumakov; L B Powers; K E Noonan; I B Roninson; I S Levenbook
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

5.  Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2.

Authors:  M Equestre; D Genovese; F Cavalieri; L Fiore; R Santoro; R Perez Bercoff
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

7.  Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families.

Authors:  P Argos; G Kamer; M J Nicklin; E Wimmer
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

8.  A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.

Authors:  K Shiroki; T Ishii; T Aoki; M Kobashi; S Ohka; A Nomoto
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.

Authors:  G Stanway; P J Hughes; R C Mountford; P Reeve; P D Minor; G C Schild; J W Almond
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.

Authors:  Soile Blomqvist; Carita Savolainen; Pia Laine; Päivi Hirttiö; Elisa Lamminsalo; Eija Penttilä; Silver Jöks; Merja Roivainen; Tapani Hovi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.